Bausch Health Companies Inc.

BHC.TOTSXHealthcare● Active

$7.49

+$0.18(+2.46%)

Market Cap$2.8B

P/E Ratio—

52W High$11.97

52W Low$6.29

Avg Volume400K

Open$7.26

Beta0.41

Free Cash Flow Financials Revenue

Bausch Health Companies Inc. (BHC.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BHC.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

BHC.TO · FCF · TTM · margin & CAGR

Free cash flow was $974.8M for FY2025 (fiscal year ending 2025-12-31), down 22.5% year-over-year The FCF margin was 9.3%. Five-year CAGR stands at +4.0%.

FY2025 Free Cash Flow$974.8M▼ -22.5% YoY

Trailing 12M (TTM)$988.5Mtrailing 4 quarters sum

FCF Margin9.3%$974.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+4.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BHC.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.38B(404M)$974.8M▼ 22.5%9.3%

FY2024$1.60B(340M)$1.26B▲ +65.4%13.1%

FY2023$1.03B(272M)$760.0M▲ +176.3%8.7%

FY2022−$728.0M(268M)−$996.0M▼ 187.1%-12.3%

FY2021$1.43B(283M)$1.14B▲ +42.5%13.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BHC.TO · P/FCF · FCF yield · FCF per share

Bausch Health Companies Inc. (BHC.TO) trades at a FCF yield of 49.34% and a price-to-free-cash-flow ratio of 2.8x. FCF per share stands at $2.67, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

49.34%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.67

TTM FCF ÷ Shares Outstanding

Price / FCF

x2.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

BHC.TO · cash flow statement · operating / investing / financing

For FY2025, Bausch Health Companies Inc. generated $1.38B in operating cash flow and spent 404M in capital expenditures, yielding $974.8M in free cash flow.

Operating Activities

+$1.38B

Cash from core business operations

2025-12-31

Investing Activities

−$605.4M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$709.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.38B) − |CapEx| (404M) = FCF ($974.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

BHC.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Bausch Health Companies Inc.YOU

BHC.TO

$974.8M-22.5%9.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Bausch Health Companies Inc. (BHC.TO) reported free cash flow of $974.8M for FY2025 (fiscal year ending 2025-12-31), down 22.5% year-over-year. The FCF margin was 9.3%.

Based on available data, Bausch Health Companies Inc. has maintained positive free cash flow for at least 14 fiscal year(s). FCF peaked at $1.95B in FY2017. The 5-year CAGR stands at +4.0%.

Bausch Health Companies Inc.'s FCF yield is 49.34% and price-to-FCF ratio is 2.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BHC.TO free cash flow · 8 questions

Bausch Health Companies Inc. free cash flow was $974.8M for FY2025, down 22.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $988.5M.

BHC.TO free cash flowBHC.TO FCFBHC.TO FCF 2025BHC.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Bausch Health Companies Inc. · Bausch Health Companies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026